Quadcap Wealth Management LLC Reduces Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Quadcap Wealth Management LLC cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 30.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,379 shares of the biotechnology company's stock after selling 604 shares during the period. Quadcap Wealth Management LLC's holdings in Axon Enterprise were worth $820,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in AXON. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth about $40,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise in the 4th quarter worth about $45,000. Stonebridge Financial Group LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth about $53,000. GPS Wealth Strategies Group LLC boosted its position in shares of Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after buying an additional 40 shares in the last quarter. Finally, Berbice Capital Management LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth about $59,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Needham & Company LLC boosted their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. Finally, Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $652.73.

Insider Activity

In related news, Director Matthew R. Mcbrady sold 400 shares of Axon Enterprise stock in a transaction on Wednesday, May 14th. The stock was sold at an average price of $718.40, for a total value of $287,360.00. Following the transaction, the director now owns 3,492 shares in the company, valued at approximately $2,508,652.80. This trade represents a 10.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua Isner sold 9,000 shares of Axon Enterprise stock in a transaction on Monday, May 12th. The shares were sold at an average price of $683.31, for a total value of $6,149,790.00. Following the completion of the transaction, the president now owns 308,714 shares in the company, valued at $210,947,363.34. The trade was a 2.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 23,764 shares of company stock valued at $14,856,635 in the last 90 days. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Trading Down 0.0%

NASDAQ AXON opened at $728.39 on Friday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $732.22. The company has a 50-day moving average of $580.48 and a 200-day moving average of $591.44. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $56.71 billion, a P/E ratio of 188.21, a P/E/G ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the prior year, the company posted $1.15 EPS. The company's quarterly revenue was up 31.3% compared to the same quarter last year. As a group, equities analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.